MedTrace Logo

Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation

NCT00521716 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-01-12

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of using WaisFix100i device for Intracapsular Femoral Fracture Fixation.

Conditions

  • Hip Fracture

Interventions

DEVICE

Intracapsular Femoral Fracture Fixation

The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.

DEVICE

WaisFix100i for Intracapsular Femoral Fracture Fixation

The WaisFix100i combines a new and unique Internal Triangular Cage nail fixator and three lag screws.

Sponsors & Collaborators

  • OrthoMediTec

    lead INDUSTRY

Principal Investigators

  • Marc Waisman, Dr. · Carmel medical Center, Haifa Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-03-31
Completion
2009-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00521716 on ClinicalTrials.gov